Emmaus rescinds EU marketing application, following negative review Endpoints News
“Because we have demonstrated the efficacy of Xyndari, as supported by the data from the trials conducted, we are disappointed in the CHMP's position,” chief ...
September 20, 2019 at 08:09AM | "marketing" - Google News
Emmaus rescinds EU marketing application, following negative review - Endpoints News
"marketing" - Google News
Nenhum comentário:
Postar um comentário